Somatuline Depot Interactions
There are 163 drugs known to interact with Somatuline Depot (lanreotide), along with 7 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 4 are major, 147 are moderate, and 12 are minor.
- View all 163 medications that may interact with Somatuline Depot
- View Somatuline Depot alcohol/food interactions (1)
- View Somatuline Depot disease interactions (7)
Most frequently checked interactions
View interaction reports for Somatuline Depot (lanreotide) and the medicines listed below.
- Adderall (amphetamine / dextroamphetamine)
- amlodipine
- Ativan (lorazepam)
- atorvastatin
- benzonatate
- Byetta (exenatide)
- cabergoline
- Celebrex (celecoxib)
- Concerta (methylphenidate)
- Creon (pancrelipase)
- Cymbalta (duloxetine)
- dronabinol
- Entresto (sacubitril / valsartan)
- Humalog (insulin lispro)
- hydrochlorothiazide
- ibuprofen
- Lamictal (lamotrigine)
- Levemir (insulin detemir)
- Lipitor (atorvastatin)
- lisinopril
- Lunesta (eszopiclone)
- Lyrica (pregabalin)
- metformin
- metoprolol
- omeprazole
- Prilosec (omeprazole)
- testosterone
- Topamax (topiramate)
- tramadol
- Vitamin D3 (cholecalciferol)
Somatuline Depot alcohol/food interactions
There is 1 alcohol/food interaction with Somatuline Depot (lanreotide).
Somatuline Depot disease interactions
There are 7 disease interactions with Somatuline Depot (lanreotide) which include:
- hepatic impairment
- renal impairment
- thyroid abnormalities
- adrenal insufficiency
- bradycardia
- cholelithiasis
- diabetes
Report options
QR code containing a link to this page
More about Somatuline Depot (lanreotide)
- Somatuline Depot consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: somatostatin and somatostatin analogs
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
